A Member of the Cancer Information Network
top menu - left Physician Resource Center CancerConsultants Patients Home divider CancerConsultants.com Home divider Cancer Consultants Espanol
Advertisement

Rectal Cancer Information Center

Rectal Cancer Information Center  

A new or recurrent diagnosis of rectal cancer often results in fear and confusion for patients and their family members. Understanding treatment options, accessing new and innovative therapies through clinical trials, as well as understanding the role of supportive care and complementary and alternative medicine are essential. Cancer screening, genetic testing and prevention are equally relevant to all individuals, especially those related to someone diagnosed with cancer.

Rectal Cancer Management

Advertisement

Cancer Tips

Cancer Tips   Sun Safety During Cancer Treatment


double arrow More cancer tips...

Rectal Cancer News

Sutent® Fails to Show Benefit in Metastatic Colorectal Cancer (07/01/2009)
The combination of the targeted therapy Sutent® (sunitinib) and FOLFIRI chemotherapy did not result in better progression-free survival than FOLFIRI alone among patients with metastatic colorectal cancer, prompting a Phase III clinical trial of the combination treatment to be stopped early. This information was made available in a press release from Pfizer.

CT Colonography May Be Appropriate Screening Test for Some High-risk Individuals (06/22/2009)
Among people at increased risk of colorectal cancer, computed tomographic (CT) colonography correctly classified 85% of the people with advanced adenomas or cancer and 88% of the people without advanced adenomas or cancer. These results were published in the Journal of the American Medical Association.

Age and Illness Increase Colonoscopy Risks (06/18/2009)
Although the risk of complications from colonoscopy is low, risk increases among the very elderly and among those with certain chronic health conditions. These results were published in the Annals of Internal Medicine.

Preemptive Skin Treatment Reduces Skin Toxicity Associated with Vectibix® in Patients with Metastatic Colorectal Cancer (06/09/2009)
Early skin treatment that is initiated prior to the start of EGFR treatment with Vectibix® (panitumumab) reduces the incidence and severity of skin toxicity and improves quality of life in patients with metastatic colorectal cancer, according to the results of a study presented at the 2009 annual meeting of the American Society of Clinical Oncology in Orlando, Florida.

Surgery Unnecessary for Most Patients with Metastatic Colorectal Cancer (06/02/2009)
Patients with newly diagnosed metastatic colorectal cancer do not need to undergo surgical removal of their tumor unless the tumor is causing complications, according to the results of a study presented at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida.

double arrow More Rectal Cancer Cancer News...

Additional Rectal Cancer Topics

  • Screening and Prevention
    Learn about techniques used in screening for cancer, as well as prevention and genetic testing.
  • Managing Side Effects
    Learn about common treatment-related side effects and strategies to manage and/or reduce them.
  • Personalized Member Center
    Register in our member center today to receive email notification of late breaking cancer news.
  • Clinical Trials
    Search our national database of clinical trials.
  • Coping with Cancer
    Read more about coping strategies for patients and caregivers.
  • Cancer Tips
    Read cancer patient tips written by patients and professionals, updated monthly.